Key Insights

Highlights

Success Rate

40% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 60/100

Termination Rate

11.5%

3 terminated out of 26 trials

Success Rate

40.0%

-46.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed with results

Key Signals

2 with results40% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (7)
Early P 1 (1)
P 1 (5)
P 2 (4)

Trial Status

Recruiting12
Not Yet Recruiting6
Terminated3
Completed2
Unknown1
Enrolling By Invitation1

Trial Success Rate

40.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT07312292Phase 2Recruiting

Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)

NCT02967848Active Not RecruitingPrimary

Liver Function Investigation With SPECT

NCT05705219RecruitingPrimary

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients

NCT07345247RecruitingPrimary

RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

NCT07314372Phase 2Not Yet Recruiting

FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma

NCT04567615Phase 2Completed

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

NCT07315633Recruiting

An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

NCT07295262Early Phase 1RecruitingPrimary

NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC

NCT04864054Phase 1Recruiting

T-Cell Therapy (ECT204) in Adults With Advanced HCC

NCT07237204Not ApplicableNot Yet RecruitingPrimary

15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial

NCT07191548Not ApplicableNot Yet Recruiting

International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE

NCT07192731Not ApplicableNot Yet Recruiting

International Study on Treatment of Liver (HCC) Patients With IRE

NCT06824974Not ApplicableRecruitingPrimary

To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients

NCT06681818Not ApplicableRecruitingPrimary

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

NCT07070362Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

NCT07055048Not Yet RecruitingPrimary

The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions

NCT07042841Enrolling By InvitationPrimary

AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer

NCT06822413Recruiting

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

NCT05195294Phase 2Not Yet Recruiting

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

NCT06777628RecruitingPrimary

Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma

Scroll to load more

Research Network

Activity Timeline